Acute coronary syndrome - Advanced risk stratification by inflammatory parameters?;Akutes koronarsyndrom - Bessere risikostratifizierung durch bestimmung von entzündungsparametern?

Medizinische Klinik

Volumn 97, Issue 2, 2002, Pages 63-69

  Link, Andreas ^a   Böhm, Michael ^a   Nickenig, Georg ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Acute coronary syndrome; Adhesion molecules; C reactive protein; Cytokines; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; HEART DEATH; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HUMAN; INFLAMMATION; LABORATORY TEST; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RESTENOSIS; REVIEW; RISK ASSESSMENT;

EID: 0037083706     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1127-y     Document Type: Review

References (52)

1. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q wave infarction enrolled in the TIMI III trial
2. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
3. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
4. ACC/AHA-Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction
5. TACTICS-TIMI 18 (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)
6. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease
7. Low grade inflammation and coronary heart disease: Prospective study und updated meta-analyses
8. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction
9. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk
10. Independent prognostic value of C-reactive protein and troponin 1 in patients with unstable angina or non-Q-wave mycardial infarction
11. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
12. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries
13. The prognostic value of serum troponin T in unstable angina
14. Emergency room triage of patients with acut chest pain by means of rapid testing für cardiac tropinin T or troponin 1
15. Plasminogen activator inhibitor in plasma: Risk for recurrent myocardial infarction
16. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: Further evidence for chronic inflammation in ischemic heart disease
17. Production of C-reactive protein and risk of coronary events in stable and unstable angina
18. Predictive value of C-reactive protein and troponin Tin patients with unstable angina: A comparative analysis
19. Risk stratification of emergency department patients with acute coronary syndromes using P-selectin
20. Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis
21. Increased soluble form of P-selectin in patients with unstable angina
22. Fibrinogen and risk of cardiovascular disease: The Franingham study
23. C-reactive protein, a sensitive marker of inflammation predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984-1992
24. A comparative study of different enzymeimmununosorbent assays for human tumor necrosis factor-alpha
25. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple risk factor intervention trial
26. Markers of myokardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
27. The prognostic value of C-reactive protein and serum amyloid A protein in servere unstable angina
28. Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study
29. Procoagulant and proinflammatory activity in acute coronary syndrome
30. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattracrant protein-1 are elevated in patients with acute myocardial infarction
31. Circulating adhesion molecules and severity of coronary atherosclerosis
32. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1
33. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
34. Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
35. Longterm effect of pravastatin on plasma concentration of Creactive protein
36. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
37. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
38. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction
39. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia
40. Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications
41. The pathogenesis of atherosclerosis - An update
42. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort
43. Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease
44. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina
45. Angiotensin-convetting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction
46. Evaluation and progression of atherosclerotic lesions in coronary arteries of children and young adults
47. Effects of statins on C-reactive protein in patients with coronary artery disease
48. Increased plasma level of soluble E-selectin in acute myocardial infarction
49. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
50. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: Results from the cardiovascular health study
51. C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction
52. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction